We report Mycobacterium bovis BCG infection in two children vaccinated with
BCG (Tokyo strain) on the first day of life. Their diagnoses were made by
biopsy of skin lesions and pus from an anterior chest wall abscess, respect
ively, yielding a positive culture of mycobacteria fully susceptible to rif
ampicin, isoniazid and ethambutol, but resistant to pyrazinamide. M. bovis
BCG was identified by a negative niacin test, absence of nitrate reductase
and resistance to pyrazinamide and cycloserine. The diagnoses were further
confirmed by a combination of an allele-specific polymerase chain reaction
(PCR) and a multiples PCR method. Based on the drug susceptibility results,
treatment with rifampicin, isoniazid and ethambutol was instituted. One pa
tient (Case 1) improved clinically and is well after treatment. However, th
e other patient with severe combined immunodeficiency died of disseminated
BCG infection in spite of intensive anti-tuberculosis therapy. Although BCG
is considered to be a safe vaccine, it should be kept in mind that complic
ations related to BCG do occur.